Published in Business

Haag-Streit USA names new CEO

This is editorially independent content
2 min read

Haag-Streit Group has selected its newest CEO for Haag-Streit USA: Olaf Felske.

Refresh me on this company.

Headquartered in Koeniz, Switzerland, Haag-Streit Group is an international Swiss medical device company that develops and manufactures medical technology products in ophthalmology, pneumology, microsurgery, and optics.

In the ophthalmic space, the company has eight group companies across the globe, including Haag-Streit USA located in Mason, Ohio.

The U.S.-based group manufactures and distributes medical equipment for eyecare professionals (ECPs), including Reliance Medical Products (which it also services)—an exam and procedure furniture brand.

And its other products?

Haag-Streit USA offers a range of medical devices, including:

  • Octopus perimeters
  • Surgical microscopes
  • Reliance medical products
  • Slit lamps and imaging
  • LENSTAR biometers
  • EyeSuite software

Click here for product details.

Now to Felske … what’s his background?

Per the company, Felske has 20 years of experience working within the healthcare, chemical, energy, and consulting industries as a strategic business and finance executive, working to drive stakeholder value and profitable business growth.

He previously served in various executive leadership roles at Medtronic plc, a global producer of medical devices and therapies such as insulin pumps, diabetes therapies, and pacemakers.

So who’s he replacing?

Jeff Sieve, who previously served as both CEO and president of Haag-Streit USA, will now serve solely as president of the company.

To note, Felske will now report directly to Haag-Streit Group CEO Thomas Bernhard.

And when is this effective?

According to a company news release, immediately.

Gotcha. Anything to keep an eye out for?

Haag-Streit will be attending the 2023 American Academy of Optometry (AAOpt) meeting in New Orleans, Louisiana, October 11-14, 2023. Catch them at Booth #1633!


How would you rate the quality of this content?